“…Clusters 0 and 5 presented increased differential gene expression of typical CEC markers, SLC4A11 , COL4A3 (Van den Bogerd et al, 2019), CDH2 (He et al, 2016), and ALCAM , compared to the other sequenced cells, suggesting these clusters were composed of therapy-grade CECs (Figure 2C and S4). Cluster 1 was identified as CECs transitioning towards a senescent phenotype due to the high differential expression of senescence markers such as MT2A (Malavolta et al, 2017), CDKN2A (p16) (Enomoto et al, 2006), and TAGLN (Benadjaoud et al, 2022) (Figure 2C and S4). Cluster 2 was composed of highly proliferative CECs expressing MKI67 (Sun and Kaufman, 2018), CENPF (Varis et al, 2006), and PTTG1 (Ersvær et al, 2020) (Figure 2C).…”